Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Basal ganglia haemorrhage
ADR ID BADD_A08882
ADR Hierarchy
17      Nervous system disorders
17.08      Central nervous system vascular disorders
17.08.01      Central nervous system haemorrhages and cerebrovascular accidents
17.08.01.039      Basal ganglia haemorrhage
24      Vascular disorders
24.07      Vascular haemorrhagic disorders
24.07.04      Nervous system haemorrhagic disorders
24.07.04.021      Basal ganglia haemorrhage
Description Bleeding within the subcortical regions of cerebral hemispheres (BASAL GANGLIA). It is often associated with HYPERTENSION or ARTERIOVENOUS MALFORMATIONS. Clinical manifestations may include HEADACHE; DYSKINESIAS; and HEMIPARESIS. | A collection of blood in BASAL GANGLIA. [MeSH]
MedDRA Code 10067057
MeSH ID D020145
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Basal ganglia haemorrhage | Basal ganglia hemorrhage | Basal ganglia bleeding | Basal Ganglia Hemorrhage | Hemorrhage, Basal Ganglia | Basal Ganglionic Hemorrhage | Ganglionic Hemorrhage, Basal | Hemorrhage, Basal Ganglionic | Hematoma, Basal Ganglia
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00033Acetylsalicylic acid0.000033%
BADD_D00151Apixaban0.000542%
BADD_D00504Clopidogrel0.000053%
BADD_D00563Dabigatran0.001346%
BADD_D00653Diclofenac0.000026%
BADD_D01599Olanzapine0.000210%
BADD_D01954Rivaroxaban0.002153%
BADD_D02150Temozolomide0.000224%
BADD_D02373Warfarin0.000084%
The 1th Page    1    Total 1 Pages